SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
Katlyn Lederer, Diana Castaño, Daniela Gómez Atria, Thomas H. Oguin, Sidney Wang, Tomaz B. Manzoni, Hiromi Muramatsu, Michael J. Hogan, Fatima Amanat, Patrick Cherubin, Kendall A. Lundgreen, Ying K. Tam, Steven H.Y. Fan, Laurence C. Eisenlohr, Ivan Maillard, Drew Weissman, Paul Bates, Florian Krammer, Gregory D. Sempowski, Norbert Pardi, Michela Locci
Topics & Concepts
Germinal centerBiologyVirologyNeutralizing antibodyAdjuvantAntibodyImmunizationMemory B cellImmunologyImmune systemAntigenMessenger RNARecombinant DNACoronavirusB cellCoronavirus disease 2019 (COVID-19)DiseaseMedicineGeneInfectious disease (medical specialty)GeneticsPathologySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesAnimal Virus Infections Studies